Pharmaceutical BioAlliance Pharma SA, a French company dedicated to the treatment and supportive care of cancer and AIDS patients, says that its drug Loramyc (miconazole) has obtained Marketing Authorization in Switzerland for the treatment of oropharyngeal candidiasis in immunocompromized patients (mainly cancer and AIDS patients with oral opportunistic infections). 25 August 2009